Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Operating Leases (2019 - 2020)

Historic Operating Leases for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Q4 2020 value amounting to $91.6 million.

  • Maravai Lifesciences Holdings' Operating Leases fell 362.76% to $91.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $91.6 million, marking a year-over-year decrease of 362.76%. This contributed to the annual value of $91.6 million for FY2020, which is 362.76% down from last year.
  • According to the latest figures from Q4 2020, Maravai Lifesciences Holdings' Operating Leases is $91.6 million, which was down 362.76% from $95.0 million recorded in Q4 2019.
  • Maravai Lifesciences Holdings' Operating Leases' 5-year high stood at $95.0 million during Q4 2019, with a 5-year trough of $91.6 million in Q4 2020.